NEW YORK (GenomeWeb) – Linkage Biosciences today announced a distribution partnership with Voden Medical Instruments.

The deal gives Voden rights to distribute Linkage's genetic testing, including the real-time PCR-based LinkSeq human leukocyte antigen (HLA) test.

"Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," Linkage Biosciences CEO Zachary Antovich said in a statement.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.